Back

anti-interleukin-18 as therapy against atherosclerosis

12 April 2024 (08:30 - 14:00)
Organised by: Logo
Congress Presentation Part of: Novel targets in atherosclerosis Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science

About the speaker

Photo
Professor Ilze Bot

Leiden Academic Center for Drug Research, Leiden (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
Circulating LIGHT/TNFSF14 levels are negatively associated with cardiovascular mortality, while intra-plaque levels are associated with symptomatic cerebrovascular disease
Doctor A. Shami (Malmo, SE)
Abstract
Presentation thumbnail
The calcium-sensing-receptor (CaSR) in adipocytes contributes to sex-differences in the susceptibility to high fat diet induced obesity and atherosclerosis
Doctor S. Maas (Aachen, DE)
Abstract
Presentation thumbnail
Human atherosclerotic plaque macrophages associate with clinical presentation and follow diverse lineage differentiation routes
Doctor K. Prange (Amsterdam, NL)
Abstract

Access the full session

Session thumbnail
Novel targets in atherosclerosis

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

12 April - 14 April 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources